Hi 3,
Fact is PNV have picked all the low hanging fruit and have now the hit competition that
is comparable and has high clinical validation.
Every PNV product apart from Novosorb Major burns has high competition and little clinical validation.
The competition is entrenched and would be buffing surgeons out to ensure their business.
Dont tell me that dont happen.
Aloha.
- Forums
- ASX - By Stock
- Livewire Markets Say Sell
Hi 3, Fact is PNV have picked all the low hanging fruit and have...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $1.590B |
Open | High | Low | Value | Volume |
$2.34 | $2.35 | $2.27 | $1.159M | 504.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 31321 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 11144 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
51 | 21502 | 2.280 |
22 | 51761 | 2.270 |
20 | 50924 | 2.260 |
22 | 43711 | 2.250 |
14 | 115265 | 2.240 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 12982 | 15 |
2.300 | 44482 | 13 |
2.310 | 33666 | 16 |
2.320 | 45817 | 13 |
2.330 | 34740 | 12 |
Last trade - 14.53pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
PNV (ASX) Chart |